PT-141 is currently available in the US under the brand name Vyleesi as an on-demand, self-administered subcutaneous HSDD therapy [3]
Are Clinical Trials Still Ongoing
This consolidated document outlines shared claims against drug manufacturers Novo Nordisk and Eli Lilly, alleging that they failed to adequately warn consumers about serious gastrointestinal side effects such as gastroparesis, intestinal obstruction, and ischemic bowel
The companies that shut down generally shared common risk factors: aggressive marketing practices, thin quality documentation, overly broad product catalogs mixing peptides with SARMs or controlled substances, and pricing that undercut the cost of legitimate synthesis
A:Yes,it's safe and efffective ,We choose safe materialsand could to the cosmetics of standard of most of areas and countries .We have did a lot in the R&D stageto get the clinical data to confirm our product is effective Q:Can I have private label
